<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neurological, including cecbrovascular, disorders frequently emerge in <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (<z:chebi fb="61" ids="27565">PAS</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>Clinical peculiarities of <z:chebi fb="61" ids="27565">PAS</z:chebi> were studied in 113 patients with cerebrovascular disturbances </plain></SENT>
<SENT sid="2" pm="."><plain>Its had mainly ischemic patogenesis </plain></SENT>
<SENT sid="3" pm="."><plain>Structure of cerebrovascular disorders was as follows: <z:hpo ids='HP_0001297'>stroke</z:hpo> (33% cases), transient ischemic lesions (10%), its combination (57%), <z:mp ids='MP_0005048'>thrombosis</z:mp> of brain venous sinuses (3%), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (27%) </plain></SENT>
<SENT sid="4" pm="."><plain>Besides it were found <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo>, <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo>, <z:hpo ids='HP_0002315'>headache</z:hpo>, <z:hpo ids='HP_0002072'>chorea</z:hpo> and some symptoms of <z:hpo ids='HP_0003473'>myasthenia</z:hpo>, <z:hpo ids='HP_0001300'>parkinsonism</z:hpo>, multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> and <z:e sem="disease" ids="C0033975" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychotic disorders</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases antibodies to <z:chebi fb="1" ids="16247">phospholipids</z:chebi> have been detected </plain></SENT>
<SENT sid="6" pm="."><plain>Secondary prophylaxis includes regular use of <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> and small doses of aspiriny </plain></SENT>
</text></document>